Company / Depreciation & Amortization
Traws Pharma, Inc. Depreciation & Amortization History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$12.0K
FY2024
5-year range
$12.0K / $14.0K
FY2020-FY2024
Trend
-14.3%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $14,000 to $12,000 over the past 2 years.
Based on SEC 10-K filings.
$12,000 in FY2024 with a 5-year CAGR of -26.2%.
Improved from $14,000 to $12,000 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -2.6%
- 5-Year CAGR
- -26.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -26.2%, indicating a declining trend.
- In FY2024, depreciation & amortization decreased 14.3% year-over-year.
- Peak depreciation & amortization was recorded in FY2015.
Company context
Key Data Points
- Altman Z-Score -42.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $12.0K | -14.3% |
| FY2023 | $14.0K | +0.0% |
| FY2022 | $14.0K | +7.7% |
| FY2021 | $13.0K | -7.1% |
| FY2020 | $14.0K | -74.5% |
| FY2019 | $55.0K | -37.5% |
| FY2018 | $88.0K | -8.3% |
| FY2017 | $96.0K | -36.0% |
| FY2016 | $150.0K | -65.4% |
| FY2015 | $434.0K | +36.1% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026